Overview

Phase 2 Chronic Low Back Pain Study

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study was to evaluate the analgesic effect and safety of hydrocodone/acetaminophen extended release compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Treatments:
Acetaminophen
Acetaminophen, hydrocodone drug combination
Hydrocodone
Oxycodone